Success Metrics

Clinical Success Rate
94.1%

Based on 317 completed trials

Completion Rate
94%(317/337)
Active Trials
20(5%)
Results Posted
23%(72 trials)
Terminated
20(5%)

Phase Distribution

Ph phase_2
48
12%
Ph phase_1
175
42%
Ph early_phase_1
5
1%
Ph not_applicable
20
5%
Ph phase_3
74
18%
Ph phase_4
84
20%

Phase Distribution

180

Early Stage

48

Mid Stage

158

Late Stage

Phase Distribution406 total trials
Early Phase 1First-in-human
5(1.2%)
Phase 1Safety & dosage
175(43.1%)
Phase 2Efficacy & side effects
48(11.8%)
Phase 3Large-scale testing
74(18.2%)
Phase 4Post-market surveillance
84(20.7%)
N/ANon-phased studies
20(4.9%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

91.6%

317 of 346 finished

Non-Completion Rate

8.4%

29 ended early

Currently Active

20

trials recruiting

Total Trials

415

all time

Status Distribution
Active(28)
Completed(317)
Terminated(29)
Other(41)

Detailed Status

Completed317
unknown41
Terminated20
Recruiting14
Withdrawn9
Not yet recruiting7

Development Timeline

Analytics

Development Status

Total Trials
415
Active
20
Success Rate
94.1%
Most Advanced
Phase 4

Trials by Phase

Early Phase 15 (1.2%)
Phase 1175 (43.1%)
Phase 248 (11.8%)
Phase 374 (18.2%)
Phase 484 (20.7%)
N/A20 (4.9%)

Trials by Status

completed31776%
recruiting143%
active_not_recruiting61%
unknown4110%
enrolling_by_invitation10%
not_yet_recruiting72%
terminated205%
withdrawn92%

Recent Activity

Clinical Trials (415)

Showing 20 of 415 trialsScroll for more
NCT06899061Phase 1

Modular Clinical Pharmacology Study to Evaluate the Drug-drug Interaction Potential and Relative Bioavailability of Saruparib

Active Not Recruiting
NCT03511118

Pharmacokinetics and Safety of Commonly Used Drugs in Lactating Women and Breastfed Infants

Recruiting
NCT07339722Phase 1

A Study of LY4515100 in Healthy Participants

Recruiting
NCT06717269Phase 1

A Single and Multiple Ascending Doses, Relative Bioavailability, Food Effect, and Drug-Drug Interaction Study of NX-5948 in Healthy Volunteers

Completed
NCT07629999Phase 1

Single and Multiple Dose Study to Evaluate Safety and Pharmacokinetics of BMS-986533 in Healthy Participants and Assessments of Food and pH Effects on Relative Bioavailability, and Drug-Drug Interaction Potential in Healthy Participants

Recruiting
NCT05483010Phase 2

Statins in Patients With Clonal Cytopenia of Undetermined Significance (CCUS) and Myelodysplastic Syndromes (MDS)

Recruiting
NCT07474649Phase 3

A Study of Bempedoic Acid/Ezetimibe/High-intensity Statin in Patients Without Cardiovascular Events

Not Yet Recruiting
NCT07717788Not Applicable

Therapeutic Prospects of HMG-CoA Reductase Inhibitors, Atorvastatin and Rosuvastatin, in Osteoporotic Patients

Completed
NCT04481789Phase 1

Clinical Pharmacology Study of Oral Edaravone in Healthy Adult Males (Drug Interaction Study and Preliminary Regimen-Finding Study)

Completed
NCT04098003Phase 4

Investigation of the Gut Microbiome and Statin Response

Completed
NCT06686615

A Study of Bempedoic Acid in Combination With Ezetimibe and Either Rosuvastatin or Atorvastatin in Patients With Primary Hypercholesterolemia or Mixed Dyslipidemia

Recruiting
NCT06982131Phase 1

A Study Investigating the Safety of RO7795081 and the Effect of RO7795081 on How the Body Processes Pitavastatin and Rosuvastatin in Otherwise Healthy Overweight or Obese Adult Participants

Recruiting
NCT02592317Phase 1

A Study to Evaluate the Effect of Multiple Doses of JNJ-56021927 on the Pharmacokinetics of Multiple Cytochrome P450 and Transporter Substrates in Participants With Castration-Resistant Prostate Cancer

Active Not Recruiting
NCT07431866Phase 1

A Clinical Study of the Effect of MK-2828 on Rosuvastatin or Furosemide in Healthy People (MK-2828-005)

Completed
NCT07216482Phase 3

A Clinical Study of Enlicitide in Participants With High Cholesterol (MK-0616-037)

Active Not Recruiting
NCT07534592Phase 1

A Study to Investigate the Effect of Elecoglipron on Rosuvastatin and Atorvastatin in Healthy Participants

Active Not Recruiting
NCT07303816Phase 4

Statins to Prevent Cancer Associated Blood Clots

Recruiting
NCT05850091Phase 4

Polygenic Risk-based Detection of Subclinical Coronary Atherosclerosis and Intervention With Statin and Colchicine

Active Not Recruiting
NCT07300280Phase 1

A Clinical Trial of Enlicitide and Rosuvastatin in Healthy Adults (MK-0616-039)

Recruiting
NCT07218900Phase 2

A Study to Investigate the Effect of AZD0780 Tablets in Combination With Rosuvastatin Tablets on Low Density Lipoprotein Cholesterol Levels (LDL-C) in Adult Participants With Dyslipidaemia

Active Not Recruiting

Drug Details

Intervention Type
DRUG
Total Trials
415